Perspective:  Fry examines the evidence for screening for problems with growth.  Here.

In a systematic review of the literature regarding height screening programs, there is incomplete data on their usefulness, but may cost approximately £30,000 per QALY.   Here.

more…

By looking at the growth of two UK cohorts - the Gateshead Millennium Baby Study and the ALSPAC cohort - against the WHO growth charts, it emerges that the WHO charts would set a lower standard of growth beyond four months of age.  Here.

DXA analysis of body fat in 1251 children suggests that gender and ethnicity have an impact which is not reflected by BMI analysis. Here.

After reviewing the literature this group present a set of criteria, with flow diagram, for referral of children for further assessment of their growth which detects 87.5% of children with Turner’s syndrome, and 76.5% of children with other disorders, with a false positive rate of 2%. Here.

Comparing the BMI of triads of mother, father and child at 7.5 years for 4,654 children in the ALSPAC cohort shows that maternal BMI is no more closely associated with child BMI than paternal is BMI - suggesting that there has been no effect of interuterine programming. Here

At age 3, children born in Hong Kong are shorter, on average, than would be expected from the WHO international standard growth charts. The authors conclude that this may be genetic, rather than related to environment. Here.